Tevogen Bio Announces 2026 Annual Meeting of Stockholders

Tevogen Bio Inc. (Nasdaq: TVGN) announced that its 2026 Annual Meeting of Stockholders (the “Annual Meeting)” is scheduled for Monday, August 24, 2026. The Annual Meeting will be held virtually. Stockholders of record as of July 23, 2026 will be entitled to receive notice of and vote at the Annual Meeting or any adjournment thereof. Because the meeting date is more than 30 days after the one-year anniversary date of the 2025 Annual Meeting, stockholder proposals submitted pursuant to Rule 14a-8 of the Securities Exchange Act of 1934 (the “Exchange Act”) for consideration at the Annual Meeting must be received by the Company’s Secretary no later than July 23, 2026, in order to be considered timely. Such proposals must also comply with rules of the U.S. Securities and Exchange Commission (the “SEC”) regarding the inclusion of stockholder proposals in proxy materials, and the Company may omit from its proxy materials any proposal that does not comply with the SEC’s rules. In addition, because the meeting date is more than 60 days after the one-year anniversary date of the 2025 Annual Meeting, in accordance with the advance notice provisions set forth in the Company’s Bylaws, in order for a stockholder proposal to be submitted outside of Exchange Act Rule 14a-8 or a director nomination submitted by a stockholder to be considered timely, written notice of such proposal or nomination must be delivered to the Company’s Secretary at the Company’s principal executive offices no later than 5 p.m. Eastern Time on July 23, 2026. All proposals or nominations intended to be considered at the Annual Meeting must comply with applicable Delaware law, SEC rules and regulations, and the requirem...